| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 563-567, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
MG Hendrix, M Daemen and CA Bruggeman
Department of Medical Microbiology, University of Limburg, Maastricht, The Netherlands.
The presence of human cytomegalovirus (HCMV) nucleic acids was demonstrated in almost all major arteries of HCMV-seropositive patients by polymerase chain reaction. The amount of HCMV nucleic acids present in the arterial wall was calculated to be less than 2 viral genomic equivalents per 2500 human genomic equivalents. No relation was observed between the presence of HCMV nucleic acids in the arterial wall and the existence of atherosclerotic changes. No differences were observed in the number of viral genomic equivalents present at sites with or without atherosclerosis. Apart from a role for HCMV in the pathogenesis of atherosclerosis, the presence of latent HCMV in the arterial tree provides a powerful system to describe the physical state of this latently present virus.
This article has been cited by other articles:
![]() |
M. A. Jarvis and J. A. Nelson Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created Equal J. Virol., March 1, 2007; 81(5): 2095 - 2101. [Full Text] [PDF] |
||||
![]() |
B. Reinhardt, T. Mertens, U. Mayr-Beyrle, H. Frank, A. Luske, K. Schierling, and J. Waltenberger HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF {beta}-receptor Cardiovasc Res, July 1, 2005; 67(1): 151 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Reinhardt, P. Schaarschmidt, A. Bossert, A. Luske, G. Finkenzeller, T. Mertens, and D. Michel Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus J. Gen. Virol., January 1, 2005; 86(1): 23 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Reeves, H. Coleman, J. Chadderton, M. Goddard, J. G. P. Sissons, and J. H. Sinclair Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo J. Gen. Virol., November 1, 2004; 85(11): 3337 - 3341. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, B. Murtuza, N. Suzuki, M. Khan, Y. Kaneda, and M. H. Yacoub Human Cytomegalovirus Immediate-Early Protein IE2-86, but not IE1-72, Causes Graft Coronary Arteriopathy in the Transplanted Rat Heart Circulation, September 24, 2002; 106(12_suppl_1): I-158 - I-162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ricotta, G. Alessandri, C. Pollara, S. Fiorentini, F. Favilli, M. Tosetti, A. Mantovani, M. Grassi, E. Garrafa, L. Dei Cas, et al. Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus Cardiovasc Res, February 1, 2001; 49(2): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Espinola-Klein, H.-J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, G. Hafner, U. Pfeifer, and J. Meyer Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? Stroke, September 1, 2000; 31(9): 2127 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tugizov, E. Maidji, J. Xiao, and L. Pereira An Acidic Cluster in the Cytosolic Domain of Human Cytomegalovirus Glycoprotein B Is a Signal for Endocytosis from the Plasma Membrane J. Virol., October 1, 1999; 73(10): 8677 - 8688. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bodaghi, M. E. P. Slobbe-vanDrunen, A. Topilko, E. Perret, R. C. R. M. Vossen, M. C. E. van Dam-Mieras, D. Zipeto, J.-L. Virelizier, P. LeHoang, C. A. Bruggeman, et al. Entry of Human Cytomegalovirus into Retinal Pigment Epithelial and Endothelial Cells by Endocytosis Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2598 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
D P Strachan, D Carrington, M A Mendall, B K Butland, P M Sweetnam, and P C Elwood Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study Heart, March 1, 1999; 81(3): 248 - 251. [Abstract] [Full Text] |
||||
![]() |
J. L. Anderson, J. F. Carlquist, J. B. Muhlestein, B. D. Horne, and S. P. Elmer Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction J. Am. Coll. Cardiol., July 1, 1998; 32(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicholson and D. P. Hajjar Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders? Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby, D. Egan, and S. Skarlatos Roles of Infectious Agents in Atherosclerosis and Restenosis: An Assessment of the Evidence and Need for Future Research Circulation, December 2, 1997; 96(11): 4095 - 4103. [Full Text] |
||||
![]() |
A.T. C. KOTSIMBOS, V. SINICKAS, E. M. GLARE, D. S. ESMORE, G. I. SNELL, E. H. WALTERS, and T. J. WILLIAMS Quantitative Detection of Human Cytomegalovirus DNA in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1241 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liuzzo, L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, and A. Maseri The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina N. Engl. J. Med., August 18, 1994; 331(7): 417 - 424. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |